Alma Sato, James W F Burns, Kesavan Sivanesan, Robyn Haysom, David Riese, Ebaney Ghotra, Kangjie R Chua, Sum-Yu C Lee, Hayato Nakanishi, Christian A Than, Kai Yuen Wong
{"title":"Comparative Outcomes of Propranolol and Corticosteroids in Infantile Haemangiomas: A Systematic Review and Meta-Analysis.","authors":"Alma Sato, James W F Burns, Kesavan Sivanesan, Robyn Haysom, David Riese, Ebaney Ghotra, Kangjie R Chua, Sum-Yu C Lee, Hayato Nakanishi, Christian A Than, Kai Yuen Wong","doi":"10.31083/BJHM54357","DOIUrl":"10.31083/BJHM54357","url":null,"abstract":"<p><strong>Aims/background: </strong>Infantile haemangiomas (IH) are the most common benign vascular tumours of infancy. Oral propranolol has become the first-line treatment, while corticosteroids remain second-line or adjunctive options when propranolol is contraindicated or insufficient. This meta-analysis provides updated comparative evidence on the efficacy and safety of oral propranolol versus oral and intralesional corticosteroids in paediatric IH.</p><p><strong>Methods: </strong>A systematic search of Ovid MEDLINE, Embase, Cochrane Library, CINAHL, and other databases was conducted on April 15, 2025, following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Data were synthesised using a random-effects model.</p><p><strong>Results: </strong>Fifteen studies met inclusion criteria (n = 1841). Propranolol demonstrated a significantly higher overall treatment effectiveness compared to corticosteroids (odds ratio [OR]: 4.96, 95% confidence interval [CI]: 2.19-11.26; <i>p</i> = 0.0001). In subgroup analyses by route, propranolol was superior to oral corticosteroids (OR: 6.56, 95% CI: 1.98-21.73; <i>p</i> = 0.002), but showed no difference compared to intralesional corticosteroids. Overall adverse event odds were lower with propranolol (OR: 0.27, 95% CI: 0.10-0.71; <i>p</i> = 0.008), specifically when compared against oral corticosteroids (OR: 0.17, 95% CI: 0.03-0.88; <i>p</i> = 0.03) and in treatment-related ulceration rates (OR: 0.18, 95% CI: 0.08-0.42; <i>p</i> < 0.0001). No significant differences were observed between treatment groups regarding overall treatment duration, recurrence rate, or surgical resection rate.</p><p><strong>Conclusion: </strong>Propranolol was associated with greater overall treatment effectiveness and a lower incidence of adverse events than corticosteroids. Greater effectiveness was observed compared with oral corticosteroids, but not intralesional corticosteroids. Intralesional corticosteroids may remain appropriate for selected patients, highlighting the importance of considering corticosteroid route and individual lesion characteristics when selecting treatment.</p><p><strong>Systematic review registration: </strong>PROSPERO (CRD420251025754).</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"54357"},"PeriodicalIF":1.7,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xuan Wang, Shiyuan Liu, Lixue Zhang, Guangpu Fan, Shuhe Yu, Xu Liang, Ziping Li, Zeye Liu
{"title":"Artificial Intelligence in Valvular Heart Disease: A Bibliometric and Knowledge-Mapping Analysis Revealing a Three-Phase Evolution Toward Integrated Clinical Intelligence.","authors":"Xuan Wang, Shiyuan Liu, Lixue Zhang, Guangpu Fan, Shuhe Yu, Xu Liang, Ziping Li, Zeye Liu","doi":"10.31083/BJHM54896","DOIUrl":"10.31083/BJHM54896","url":null,"abstract":"<p><strong>Aims/background: </strong>The application of artificial intelligence (AI) in valvular heart disease (VHD) has advanced significantly in recent years. However, a systematic evaluation of this field's historical development, knowledge structure, and global research patterns has yet to be conducted. This paper aims to outline the global evolution of AI research in VHD utilizing bibliometric and knowledge-mapping methods.</p><p><strong>Methods: </strong>Publications related to AI and VHD from 1991 to 2025 were retrieved from the Web of Science Core Collection database to investigate research progress. CiteSpace software was employed for bibliometric and knowledge mapping analyses, assessing indicators such as publication trends, keyword networks, collaboration patterns, co-citation relationships, and emerging topics.</p><p><strong>Results: </strong>A total of 3291 pieces of literature were identified. Research productivity remained low until the year before 2004, followed by steady growth and a sharp increase after 2015, culminating in 461 articles by the end of 2025. Network analysis revealed three sequential stages: image-assisted applications, prediction modeling, and recent advancements in deep-learning-based integrated systems. The United States accounted for the largest research volume, while England and Germany served as core nodes in the international cooperation network. Co-citation analysis identified significant clinical guidelines and pioneering interventional studies as key intellectual pillars in this domain.</p><p><strong>Conclusion: </strong>Over the past 35 years, significant progress has been achieved, transitioning from computer systems used solely for image analysis to more integrated clinical applications. Currently, deep learning techniques are increasingly prevalent, accompanied by a focus on multimodal data integration and a stronger linkage between computational methods and clinical decision-making.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"54896"},"PeriodicalIF":1.7,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Effect of Repetitive Facilitative Exercise Combined With Electromyography Biofeedback in Promoting Limb Function Rehabilitation in Patients With Post-Stroke Hemiplegia.","authors":"Bin Hu, Dejun Chai","doi":"10.31083/BJHM62007","DOIUrl":"https://doi.org/10.31083/BJHM62007","url":null,"abstract":"<p><strong>Aims/background: </strong>Hemiplegia is a common complication following a stroke, resulting in decreased motor function. Although various treatment options are available, there is currently insufficient evidence to determine the definitive superiority of any single treatment modality, and the effectiveness of using a single therapy remains limited. Therefore, this study aims to investigate the efficacy and safety of combining repetitive facilitative exercise (RFE) with electromyography (EMG) biofeedback in managing patients with post-stroke hemiplegia.</p><p><strong>Methods: </strong>This retrospective study included 106 patients with post-stroke hemiplegia who were treated at The Second Affiliated Hospital of Qiqihar Medical University, China, between January 2022 and January 2024. Patients who received RFE alone were included in the RFE group (<i>n</i> = 51), while those who received the combination of RFE and EMG biofeedback treatment were included in the RFE+EMG group (<i>n</i> = 55). Both groups were treated continuously for 12 weeks. The limb function (Fugl-Meyer Assessment [FMA]), balance ability (Berg Balance Scale [BBS], Timed Up and Go Test [TUGT], 10-Meter Walk Test [10MWT]), and quality of life (Stroke Specific Quality of Life Scale [SS-QOL]) were comparatively assessed between the two groups before treatment and 12 weeks after treatment. Additionally, the incidence of adverse events throughout the treatment period was recorded for both groups.</p><p><strong>Results: </strong>After treatment, the FMA scores showed significant improvements in both groups compared to their pre-treatment values (<i>p</i> < 0.05). Notably, the RFE+EMG group exhibited significantly higher improvements in upper extremity, lower extremity and overall scores compared to the RFE group after treatment (<i>p</i> < 0.05). Following the intervention, both groups demonstrated a substantial increase in the BBS score compared to their scores before treatment (<i>p</i> < 0.05). In contrast, the TUGT and 10MWT were significantly shortened in both groups compared to their times before treatment (<i>p</i> < 0.05). Notably, the RFE+EMG group exhibited significantly higher BBS scores (<i>p</i> < 0.05) and significantly shorter TUGT and 10MWT times compared to the RFE group after treatment (<i>p</i> < 0.05). After treatment, the SS-QOL scores increased significantly in both groups compared to their scores before treatment (<i>p</i> < 0.05). Notably, the RFE+EMG group exhibited significantly higher scores in energy, family roles, language, mobility, mood, personality, self-care, social roles, thinking, upper extremity function, vision and work/productivity compared to the RFE group after treatment (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>The combination of RFE and EMG biofeedback shows promising effects in limb functional recovery, improving balance ability, and enhancing quality of life in patients with post-stroke hemiplegia, while also demonstratin","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"62007"},"PeriodicalIF":1.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Why We Need a College of Intensive Care Medicine (UK).","authors":"Jack Parry-Jones","doi":"10.31083/BJHM57800","DOIUrl":"https://doi.org/10.31083/BJHM57800","url":null,"abstract":"","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"57800"},"PeriodicalIF":1.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cheng-Yang Xu, Li-Ye Zhong, Pei-Long Lai, Chun-Yan Sun, Dong-Hua He, Ai Guan, Yi Xu, Kaini Shen, Jian Li
{"title":"The Effectiveness of Teclistamab in Patients With Relapsed/Refractory Light Chain Amyloidosis: A Multicenter Retrospective Study.","authors":"Cheng-Yang Xu, Li-Ye Zhong, Pei-Long Lai, Chun-Yan Sun, Dong-Hua He, Ai Guan, Yi Xu, Kaini Shen, Jian Li","doi":"10.31083/BJHM62006","DOIUrl":"10.31083/BJHM62006","url":null,"abstract":"<p><strong>Aims/background: </strong>Teclistamab is a B-cell maturation antigen (BCMA)-directed bispecific monoclonal antibody recommended for relapsed/refractory multiple myeloma (RRMM) management. However, some small-scale studies support the application of teclistamab in relapsed/refractory light chain (RRAL) amyloidosis, primarily secondary to multiple myeloma (MM). Therefore, this study evaluated the efficacy and safety profile of teclistamab in daratumumab-pretreated RRAL amyloidosis patients.</p><p><strong>Methods: </strong>After dose escalation, 19 patients across five centers, enrolled from October 2024 to July 2025, received teclistamab at a fixed dose (60 mg, n = 13) or weight-based administration (1.5 mg/kg, n = 6). Patients were followed up, and treatment response was monitored by evaluating hematologic, hepatic, cardiac, and renal involvement, as well as by examining the associated complications. The dosing frequency was reduced as hematologic efficacy improved, adjusted by the treating physician.</p><p><strong>Results: </strong>At a median 4.0-month follow-up (interquartile range [IQR], 3-8), teclistamab demonstrated profound hematologic responses and organ improvement. 94.7% of patients achieved a stringent difference between involved and uninvolved free light chain (dFLC) response at a median time of 18.5 days. The weight-based and fixed-dose groups had comparable time to stringent dFLC response (median 20.5 days [IQR, 18-26] vs 17.5 days [IQR, 11-27], <i>p</i> = 0.385). Furthermore, 68.4% of the patients showed a significant cardiac response. Adverse events observed following treatment included cytokine release syndrome (ten events, all ≤grade 2), immune effector cell-associated neurotoxicity syndrome (one event, grade 1), and associated infections (ten events, 4 ≥grade 3).</p><p><strong>Conclusion: </strong>These results indicate teclistamab as a practical option for daratumumab-exposed RRAL amyloidosis, supporting that fixed-dose strategy and timely reduction of dosing frequency guided by therapeutic efficacy appear to be feasible real-world approaches.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"62006"},"PeriodicalIF":1.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cheng Gong, Runqi Zhong, Na Zhao, Wei Shuai, Yaoshan Dun, Yuan Lin
{"title":"Effects of Different Stimulation Parameters on the Efficacy of Transcranial Direct Current Stimulation for Post-Stroke Dysphagia: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Cheng Gong, Runqi Zhong, Na Zhao, Wei Shuai, Yaoshan Dun, Yuan Lin","doi":"10.31083/BJHM52794","DOIUrl":"10.31083/BJHM52794","url":null,"abstract":"<p><strong>Aims/background: </strong>Transcranial direct current stimulation (tDCS) is a promising intervention for post-stroke dysphagia (PSD). However, no consensus has been reached regarding the optimal stimulation parameters. This study aimed to identify the optimal tDCS stimulation protocol for patients with PSD.</p><p><strong>Methods: </strong>Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically searched seven databases (Web of Science, PubMed, Embase, Cochrane Library, WanFang, CNKI, and VIP) for relevant trials, covering the period from database inception to 1 January 2025. Statistical analyses were performed with Review Manager 5.40, with the choice of fixed- or random-effects model guided by <i>I<sup>2</sup></i> values.</p><p><strong>Results: </strong>Overall, tDCS significantly improved swallowing function compared with control conditions for both outcome measures in which higher scores indicate better swallowing function (standardized mean difference (SMD) = 1.16, <i>p</i> < 0.001) and those in which lower scores indicate better swallowing function (SMD = -0.85, <i>p</i> < 0.001). In the subgroup analysis by stimulation intensity, 1.4 mA yielded the largest point estimate among positive-direction outcomes (SMD = 1.91, <i>p</i> = 0.04), whereas 1.8 mA yielded the largest effect estimate among negative-direction outcomes (SMD = -0.82, <i>p</i> = 0.04). Both single-session tDCS lasting 20 minutes and 30 minutes significantly improved swallowing function in patients with PSD (positive outcome indicators, 20 min: SMD = 1.18, <i>p</i> < 0.001; 30 min: SMD = 1.28, <i>p</i> = 0.02, subgroup difference: <i>p</i> = 0.86; negative outcome indicators, 20 min: SMD = -0.69, <i>p</i> < 0.001; 30 min, SMD = -0.70, <i>p</i> = 0.005, subgroup difference, <i>p</i> = 0.89). However, prolonging single-session duration to 30 minutes did not confer superior therapeutic efficacy relative to 20 minutes. tDCS was effective for both supratentorial and infratentorial lesions (positive outcome indicators, SMD = 1.57, <i>p</i> < 0.001; negative outcome indicators, SMD = -0.73, <i>p</i> < 0.001). Compared with the control group, swallowing function was improved in acute, sub-acute and chronic stroke patients treated with tDCS intervention (positive outcome indicators, Acute: SMD = 1.17, <i>p</i> < 0.0001; Subacute: SMD = 1.72, <i>p</i> < 0.0001; Chronic: SMD = 0.59, <i>p</i> = 0.0004; negative outcome indicators, Acute: SMD = -0.78, <i>p</i> < 0.0001; Sub-acute: SMD = -0.91, <i>p</i> = 0.0001; Chronic: SMD = -0.77, <i>p</i> = 0.001). tDCS significantly improved swallowing function in patients with pseudobulbar palsy (SMD = -0.86, <i>p</i> = 0.001), whereas it showed no obvious therapeutic effect on patients with bulbar palsy (SMD = -0.48, <i>p</i> = 0.07).</p><p><strong>Conclusion: </strong>tDCS yields favorable effects on swallowing function in patients with PSD when administered to the lesional hemisp","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"52794"},"PeriodicalIF":1.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Percutaneous Endoscopic Gastrostomy in Older Palliative Inpatients at Nutritional Risk: Procedural Burden and Survival in a Six-Year Retrospective Cohort.","authors":"Nermin Mutlu Bilgiç, Güldan Kahveci, Hüseyin Aykut, Ekmel Burak Özşenel, Beytullah Özcan, Sema Basat","doi":"10.31083/BJHM55660","DOIUrl":"https://doi.org/10.31083/BJHM55660","url":null,"abstract":"<p><strong>Aims/background: </strong>Percutaneous endoscopic gastrostomy (PEG) provides long-term enteral access in selected older palliative-care inpatients, but its clinical value depends on prognosis, post-procedure trajectory, and recurrent tube-related interventions. This study aimed to evaluate PEG utilisation, repeat PEG-related procedural burden, and post-PEG outcomes among palliative-care inpatients aged 65 years or older at nutritional risk.</p><p><strong>Methods: </strong>This retrospective single-centre cohort included older palliative-care inpatients who underwent PEG placement or PEG-related procedures between January 2020 and December 2025. Among patients with available Nutrition Risk Screening 2002 (NRS-2002) screening data, all met the standard nutritional-risk threshold (score ≥3). The primary outcome was 90-day all-cause mortality after the index PEG date. Kaplan-Meier methods, univariable comparisons, parsimonious logistic regression, and a 90-day censored Cox model were used. Missing-data denominators, survival follow-up availability, and multicollinearity diagnostics were reported.</p><p><strong>Results: </strong>The analytic cohort included 141 patients aged 65 years or older; median age was 82.0 years (range 65-112), 60.3% were aged ≥80 years, and 60.3% were female. NRS-2002 score was ≥5 in 84 of 138 patients (60.9%), and serum albumin was <30 g/L in 110 of 141 patients (78.0%). Overall, 181 PEG-related procedures were recorded, and repeat PEG-related procedures occurred in 23 patients (16.3%). Valid survival follow-up was available for 105 patients. Kaplan-Meier mortality estimates were 5.7% at 30 days, 25.7% at 90 days, 43.8% at 180 days, and 53.3% at 365 days; median post-PEG survival was 326 days. In multivariable models, age, lower albumin, and log2-transformed NLR were not statistically significant independent predictors of 90-day mortality.</p><p><strong>Conclusion: </strong>Older palliative-care inpatients undergoing PEG placement or PEG-related procedures had substantial nutritional risk, early and 365-day mortality, and measurable repeat-procedure burden. Findings support cautious, goal-oriented PEG decision-making rather than causal inference about procedural benefit.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"55660"},"PeriodicalIF":1.7,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association Between the Neutrophil-to-Lymphocyte Ratio and Severity of Liver Injury in Children With Kawasaki Disease.","authors":"Qing Ye, Zhufei Chu","doi":"10.31083/BJHM62005","DOIUrl":"https://doi.org/10.31083/BJHM62005","url":null,"abstract":"<p><strong>Aims/background: </strong>Kawasaki disease (KD) is an acute febrile illness characterized by rash in children. The disease can cause liver damage, and severe cases can affect the growth and development of children. This study aimed to explore the correlation between the neutrophil-to-lymphocyte ratio (NLR) and the severity of liver function injury in KD.</p><p><strong>Methods: </strong>A total of 123 children with KD admitted to the Affiliated Yangming Hospital of Ningbo University from September 2022 to September 2025 were selected and divided into a normal liver function group (normal group) and an abnormal liver function group (abnormal group) according to the presence of liver function injury. Routine blood and liver function indices were assessed in children with KD. According to alanine aminotransferase (ALT) levels, the children in the abnormal group were further divided into three groups: mild, moderate, and severe. Routine blood and liver function indices were compared among the three groups. Multivariate logistic regression analysis was performed to identify independent risk factors for liver function impairment in children with KD. The correlations between NLR and C-reactive protein (CRP) and liver function indices were analyzed using Spearman's correlation. A sensitivity analysis was also performed using ALT as the upper limit of normal pediatric sex-specific values.</p><p><strong>Results: </strong>The levels of neutrophils, NLR, and procalcitonin (PCT) in the abnormal group were significantly higher than those in the normal group (<i>p</i> < 0.05), while lymphocyte levels were significantly lower (<i>p</i> < 0.05). Among the 123 children with KD, 47 had liver function impairment, with higher aspartate aminotransferase (AST), ALT, and total bilirubin (TBIL) levels. The comparison of NLR among the three groups was statistically significant, and NLR increased with increasing severity and liver function injury (<i>p</i> < 0.05). After adjusting for potential confounding factors, including age, CRP, intravenous immunoglobulin (IVIG) response, and coronary artery lesions, NLR remained an independent risk factor for liver function impairment in children with KD (<i>p</i> < 0.05). NLR was positively correlated with AST, ALT, Gamma-Glutamyl Transferase (GGT) and TBIL (<i>p</i> < 0.05). Receiver operating characteristic (ROC) curve analysis showed that NLR achieved an area under the curve (AUC) of 0.664 (95% confidence interval (CI): 0.574-0.747) for identifying children with KD and liver function impairment, with an optimal cutoff value of 4.702 (sensitivity, 46.8%; specificity, 82.9%).</p><p><strong>Conclusion: </strong>NLR is significantly associated with the severity of liver function impairment in children with KD. As an indicator readily obtained from routine blood tests, NLR may help clinicians identify children at increased risk of liver function injury.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"62005"},"PeriodicalIF":1.7,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
John Sandars, Rakesh Patel, June Jones, Matthew James
{"title":"Supporting the Resident Doctor When Their Personal and Professional Values and Morals Are Challenged.","authors":"John Sandars, Rakesh Patel, June Jones, Matthew James","doi":"10.31083/BJHM55922","DOIUrl":"https://doi.org/10.31083/BJHM55922","url":null,"abstract":"<p><p>Challenges to personal and professional values and morals are commonly experienced by resident doctors during clinical practice, with an associated psychological reaction. This psychological reaction is on a continuum, ranging from transient discomfort, and in repeated cases, to moral distress and moral injury. This educational guidance article offers several practical approaches for clinical educators to support resident doctors when their values and morals have been challenged. Three complementary approaches are described: debriefing, speaking up to address systemic factors and psychological support. These approaches address the important individual and systemic factors associated with values and moral challenges, with associated benefits for wellbeing and quality of patient care.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"55922"},"PeriodicalIF":1.7,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Model for Identifying Obesity Status Based on Inflammatory and Metabolic Indicators: The Role of the CRP-TG-GLU Index.","authors":"Ling Xu, Changlin Zhou, Jun Zhao","doi":"10.31083/BJHM52648","DOIUrl":"10.31083/BJHM52648","url":null,"abstract":"<p><strong>Aims/background: </strong>Obesity is a major public health concern. However, conventional anthropometric measures do not adequately reflect underlying inflammation and insulin resistance. This study aimed to validate a nomogram model for identifying obesity risk in adults, centered on the C-reactive protein-Triglyceride-Glucose composite index (CTI) and incorporating routinely available clinical indicators.</p><p><strong>Methods: </strong>A single-center retrospective observational study was conducted. A total of 360 adult subjects who completed health examinations at our hospital between January 2022 and December 2024 were consecutively enrolled. Participants were categorized into obese and non-obese groups according to World Health Organization (WHO) criteria (body mass index [BMI] ≥30 kg/m<sup>2</sup>) and randomly divided into a training set (n = 252) and an internal validation set (n = 108) at a 7:3 ratio. The core predictor, CTI, was calculated as follows: CTI = 0.412 × Ln(hs-CRP, mg/L) + Ln[TG(mg/dL) × FPG(mg/dL) / 2]. In the training set, independently associated factors were identified using univariate and multivariate logistic regression to construct the final model. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC) with bootstrap correction, while calibration was evaluated using calibration curves and the Hosmer-Lemeshow test. The incremental value of CTI was assessed using the Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI), and clinical utility was evaluated using decision curve analysis (DCA).</p><p><strong>Results: </strong>Among the 360 included subjects, the prevalence of obesity was 17.22%. Baseline characteristics were comparable between the training and validation sets (<i>p</i> > 0.05). Multivariate analysis identified waist circumference (WC) and CTI as independent factors associated with obesity (WC: OR = 1.117, 95% CI: 1.072-1.165, <i>p</i> < 0.001; CTI: OR = 1.684, 95% CI: 1.262-2.246, <i>p</i> < 0.001). The model demonstrated good discriminative performance, with a bootstrap-corrected AUC of 0.795, and satisfactory calibration (H-L test <i>p</i> > 0.05). Incremental value analysis showed that adding CTI to WC significantly improved risk reclassification (NRI = 0.242, <i>p</i> = 0.006; IDI = 0.072, <i>p</i> = 0.002). Sensitivity analysis using the Chinese BMI criterion (≥28 kg/m<sup>2</sup>) yielded consistent results. Decision curve analysis demonstrated a clinical net benefit across a broad range of threshold probabilities.</p><p><strong>Conclusion: </strong>CTI, as a composite indicator reflecting both inflammation and insulin resistance, is independently associated with obesity and provides incremental value for risk stratification beyond WC alone. The proposed nomogram, based on routinely available health examination data, provides a convenient approach for obesity risk assessment in health management settings and","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 10","pages":"52648"},"PeriodicalIF":1.7,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}